GRP
TARS icon

Global Retirement Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Global Retirement Partners’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
+47
New +$3K ﹤0.01% 3875
2025
Q4 		$5.98K Buy
73
+19
+35% +$1.42K ﹤0.01% 3376
2025
Q3 		$3.21K Buy
54
+6
+13% +$295 ﹤0.01% 3145
2025
Q2 		$1.94K Buy
+48
New +$2.16K ﹤0.01% 3250
2024
Q4 		– Sell
-38
Closed -$1.25K – 3775
2024
Q3 		$1.25K Buy
+38
New +$1.07K ﹤0.01% 3089

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Global Retirement Partners's TARS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 47 shares worth $2.96K. The stake represents ﹤0.01% of the portfolio and ranks #3875 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TARS as recently as Q4 2025.

Global Retirement Partners first reported a position in TARS in Q3 2024 and has held it in 5 quarters since. The position peaked at $5.98K in Q4 2025. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Global Retirement Partners held 47 shares of Tarsus Pharmaceuticals worth $2.96K as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3875 holding.
  • Global Retirement Partners first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Global Retirement Partners's Tarsus Pharmaceuticals position peaked at $5.98K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.